Asia-Pacific Intrauterine Devices Market By Product Type - (Hormonal Intrauterine Device, Copper Intrauterine Device) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Asia-Pacific Intrauterine Devices Market By Product Type - (Hormonal Intrauterine Device, Copper Intrauterine Device) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 1095 | Pages: 136 | October 2018 | Region: Asia Pacific


The Asia-Pacific Intrauterine devices (IUD’S) Market was worth $ 399.63 million in 2018 and estimated to reach $ 500.4 million by the end of 2023 with a growing potential of 4.60 %. Asia-Pacific accounts to hold the largest share in the market.

Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long-time period. It is injected into the uterus, and their primary aim is to inhibit the fertilization of the egg by causing changes, such as toxicity or thickening of the cervical mucus, thus inhibiting fertilization by a sperm. Mirena, Skyla and Paragard are some of the prominent brands available in the market. In Asia-Pacific region, most of the people are adopting to modern contraception such as oral pill, injectable contraceptives, condoms, implants, IUDs and male or female sterilisation. Modern contraceptive methods are more effective than traditional methods. For example, the rate of sterilisation fails less than 1 per cent for modern contraception’s in comparison to 25 per cent for periodic abstinence.

Asia-Pacific Intrauterine Device market is mainly driven by the factors such as Advancement in technical innovations, increasing prevalence of STD’S (Sexually transmitted diseases), instant health benefits other than birth control, increasing government initiatives to prevent unwanted abortions and pregnancies. The factors that are hindering the growth of the market are issues of Infertility, Religious and cultural opposition, Economic constraints, ectopic pregnancy, pelvic inflammatory infection, and Limited access to contraception.

The Asia-Pacific Intrauterine Devices market is broadly categorized based on product type into Hormonal intrauterine device and Copper intrauterine device. The largest share in the market is held by Hormonal IUD’S. Since, they have less risks compared to non-hormonal IUD’S.

Key players influencing the Asia-Pacific intrauterine devices market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer AG, Teva Pharmaceutical, Pfizer, Mylan laboratories, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Hormonal Intrauterine Devices      

                                5.1.2 Copper intrauterine Devices            

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 China            

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Agile Therapeutics                  

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Actavis PLC                 

                8.3 ANI Pharmaceuticals                              

                8.4 Bayer                            

                8.5 Teva Pharmaceutical                              

                8.6 Besins HealthCare                   

                8.7 Brecuro Medical                       

                8.8 Effik International                    

                8.9 Eurogine                      

                8.10 HLL Lifecare                             

                8.11 HRA Pharma                            

                8.12 Lupin Pharmaceuticals                        

                8.13 Okamato Industries                             

                8.14 Pfizer                          

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Market outlook and Investment oppurtunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific intrauterine Devices Market By Product Type, From 2018-2023( USD Million )  
  2. Asia-Pacific Hormonal Intrauterine Devices Market By Region, From 2018-2023( USD Million )    
  3. Asia-Pacific Copper intrauterine Devices Market By Region, From 2018-2023( USD Million )   
  4. Japan intrauterine Devices Market By Product Type, From 2018-2023( USD Million ) 
  5. China intrauterine Devices Market By Product Type, From 2018-2023( USD Million )  
  6. India intrauterine Devices Market By Product Type, From 2018-2023( USD Million ) 
Middle East and Africa Anti-neoplastic Agents Market by product type ( personalised medicine, biological agents and chemotherapeutic agents) , by end user( hospitals, clinics, cancer rehabilitation centres and ambul...
Middle East and Africa Anti-neoplastic Agents Market by product type ( personalised medicine, biological agents and chemotherapeutic agents) , by end user( hospitals, clinics, cancer rehabilitation centres and ambul...
Latin America Anti-neoplastic Agents Market By Product Type ( Personalised Medicine, Biological Agents And Chemotherapeutic Agents) , By End User( Hospitals, Clinics, Cancer Rehabilitation Centres And Ambulatory Sur...
Asia Pacific Anti-neoplastic Agents Market By Product Type ( Personalised Medicine, Biological Agents And Chemotherapeutic Agents) , By End User( Hospitals, Clinics, Cancer Rehabilitation Centres And Ambulatory Surg...
Europe Anti-neoplastic Agents Market By Product Type ( Personalised Medicine, Biological Agents And Chemotherapeutic Agents) , By End User( Hospitals, Clinics, Cancer Rehabilitation Centres And Ambulatory Surgical C...
North America Anti-neoplastic Agents Market By Product Type ( Personalised Medicine, Biological Agents And Chemotherapeutic Agents) , By End User( Hospitals, Clinics, Cancer Rehabilitation Centres And Ambulatory Sur...
Anti-neoplastic Agents Market - Segmented By Product Type, End-User, And Region - Global Growth, Trends, And Forecast -2023...
Middle East And Africa Bone Densitometer Devices Market By Specialty (Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Gynecology), By Services (Tele-Consultation, Tele-Monitoring, Tele-Education, ...
Latin America Bone Densitometer Devices Market By Specialty (Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Gynecology), By Services (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Surg...
Europe Bone Densitometer Devices Market By Specialty (Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Gynecology), By Services (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Surgery, Te...
North America Bone Densitometer Devices Market By Specialty (Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Gynecology), By Services (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Surg...
Bone Densitometer Devices Market By Specialty (Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Gynecology), By Services (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Surgery, Tele-Trai...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.